Relay Therapeutics, Inc.
US ˙ NasdaqGM ˙ US75943R1023

SecurityRLAY / Relay Therapeutics, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership1,432,003 shares
Latest Disclosed Value $ 14,248,431
Morgan Stanley reports 29.05% decrease in ownership of RLAY / Relay Therapeutics, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 1,432,003 shares of Relay Therapeutics, Inc. (US:RLAY) valued at $14,248,430 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 2,018,464 shares of Relay Therapeutics, Inc.. This represents a change in shares of -29.05% during the quarter. The current value of the position is $20,821,324 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F RELAY THERAPEUTICS COM 75943R102 1,432,003 -586,461 -29.05 14,248 -16.56 0.0009
2026-05-27 2025-12-31 13F/A-1 RELAY THERAPEUTICS COM 75943R102 2,018,464 254,368 14.42 17,076 85.45 0.0010
2026-02-13 2025-12-31 13F RELAY THERAPEUTICS COM 75943R102 2,018,464 254,368 17,076 0.0010
2026-05-27 2025-09-30 13F/A-1 RELAY THERAPEUTICS COM 75943R102 1,764,096 341,750 24.03 9,209 87.12 0.0006
2025-11-14 2025-09-30 13F RELAY THERAPEUTICS COM 75943R102 1,764,096 341,750 9,209 0.0006
2025-08-15 2025-06-30 13F RELAY THERAPEUTICS COM 75943R102 1,422,346 -170,840 -10.72 4,921 17.90 0.0003
2025-05-15 2025-03-31 13F RELAY THERAPEUTICS COM 75943R102 1,593,186 292,416 22.48 4,174 -22.11 0.0003
2025-05-15 2024-12-31 13F/A-1 RELAY THERAPEUTICS COM 75943R102 1,300,770 338,659 35.20 5,359 -21.32 0.0004
2025-02-14 2024-12-31 13F RELAY THERAPEUTICS COM 75943R102 1,300,770 338,659 5,359 0.0004
2025-05-14 2024-09-30 13F/A-2 RELAY THERAPEUTICS COM 75943R102 962,111 -280,167 -22.55 6,812 -15.90 0.0005
2025-02-14 2024-09-30 13F/A-1 RELAY THERAPEUTICS COM 75943R102 962,111 -280,167 6,812 0.0005
2024-11-14 2024-09-30 13F RELAY THERAPEUTICS COM 75943R102 962,111 -280,167 6,812 0.0001
2025-05-14 2024-06-30 13F/A-2 RELAY THERAPEUTICS COM 75943R102 1,242,278 85,257 7.37 8,100 -15.66 0.0006
2024-10-17 2024-06-30 13F/A-1 RELAY THERAPEUTICS COM 75943R102 1,242,278 85,257 8,100 0.0006
2024-08-14 2024-06-30 13F RELAY THERAPEUTICS COM 75943R102 1,242,278 85,257 8,100 0.0006
2024-10-17 2024-03-31 13F/A-2 RELAY THERAPEUTICS COM 75943R102 1,157,021 428,317 58.78 9,603 19.69 0.0008
2024-08-16 2024-03-31 13F/A-1 RELAY THERAPEUTICS COM 75943R102 1,157,021 428,317 9,603 0.0001
2024-05-15 2024-03-31 13F RELAY THERAPEUTICS COM 75943R102 1,157,021 428,317 9,603 0.0008
2024-08-16 2023-12-31 13F/A-1 RELAY THERAPEUTICS COM 75943R102 728,704 71,163 10.82 8,023 45.11 0.0007
2024-02-13 2023-12-31 13F RELAY THERAPEUTICS COM 75943R102 728,704 71,163 8,023 0.0007
2023-11-15 2023-09-30 13F RELAY THERAPEUTICS COM 75943R102 657,541 -119,926 -15.43 5,530 -43.37 0.0006
2023-08-14 2023-06-30 13F RELAY THERAPEUTICS COM 75943R102 777,467 215,333 38.31 9,765 5.47 0.0010
2023-05-15 2023-03-31 13F RELAY THERAPEUTICS COM 75943R102 562,134 -1,807,210 -76.27 9,258 -73.85 0.0010
2023-02-14 2022-12-31 13F RELAY THERAPEUTICS COM 75943R102 2,369,344 2,027,003 592.10 35,398 362.22 0.0040
2022-11-14 2022-09-30 13F RELAY THERAPEUTICS COM 75943R102 342,341 -283,783 -45.32 7,658 -26.98 0.0010
2022-10-27 2022-06-30 13F/A-1 RELAY THERAPEUTICS COM 75943R102 626,124 194,644 45.11 10,487 -18.80 0.0014
2022-08-15 2022-06-30 13F RELAY THERAPEUTICS COM 75943R102 626,124 194,644 10,487 0.0003
2022-10-27 2022-03-31 13F/A-1 RELAY THERAPEUTICS COM 75943R102 431,480 -92,013 -17.58 12,915 -19.66 0.0017
2022-05-13 2022-03-31 13F RELAY THERAPEUTICS COM 75943R102 431,480 -92,013 12,915 0.0017
2022-02-14 2021-12-31 13F RELAY THERAPEUTICS COM 75943R102 523,493 76,702 17.17 16,076 14.12 0.0020
2021-11-15 2021-09-30 13F RELAY THERAPEUTICS COM 75943R102 446,791 -122,854 -21.57 14,087 -32.41 0.0019
2021-08-23 2021-06-30 13F/A-1 RELAY THERAPEUTICS COM 75943R102 569,645 79,037 16.11 20,843 22.90 0.0027
2021-08-16 2021-06-30 13F RELAY THERAPEUTICS COM 75943R102 569,645 79,037 20,843 0.0006
2021-05-17 2021-03-31 13F RELAY THERAPEUTICS COM 75943R102 490,608 361,849 281.03 16,960 216.95 0.0025
2021-02-16 2020-12-31 13F RELAY THERAPEUTICS COM 75943R102 128,759 24,434 23.42 5,351 20.44 0.0008
2020-11-13 2020-09-30 13F RELAY THERAPEUTICS COM 75943R102 104,325 104,325 4,443 0.0009
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.